| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $452K | +341.0% | +786.3% |
| SG&A Expense | $159K | +59.9% | +3.4% |
| Operating Income | -$496K | -121.4% | -43.3% |
| Pre-tax Income | -$283K | -897.8% | +27.9% |
| Net Income | -$283K | -897.8% | +27.9% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $14K | +361.2% | -58.2% |
| Total Assets | $156K | +6.0% | -1.7% |
| Current Liabilities | $3.1M | +10.0% | +146.1% |
| Total Liabilities | $3.1M | +10.0% | +146.1% |
| Stockholders' Equity | -$2.9M | -10.2% | -167.8% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$289K | — | — |
| Investing Cash Flow | -$17K | — | — |
| Financing Cash Flow | $316K | — | — |
| — |